8
14 Publications 2018 du SPOG Ci-après est présentée une liste des publications parues en 2018 dans des revues scientifiques reconnues, auxquelles des collaborateurs du réseau du SPOG ont participé activement. 1 Adamczick C, Dierig A, Welzel T, Schifferli A, Blum J, Ritz NJBID. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany – a case report. BMC Infectious Diseases. (2018); 18(1), 495. doi:10.1186/s12879-018-3394-0. 2.620 2 Amoon AT, Crespi CM, Ahlbom A, Bhatnagar M, Bray I, Bunch KJ, Clavel J, Feychting M, Hémon D, Johansen C, Kreis C, Ma- lagoli C, Marquant F, Pedersen C, Raaschou-Nielsen O, Röösli M, Spycher BD, Sudan M, Swanson J, Tittarelli A, Tuck DM, Tynes T, Vergara X, Vinceti M, Wünsch-Filho V, Kheifets L. Proximity to overhead power lines and childhood leukaemia: an in- ternational pooled analysis. British Journal of Cancer. (2018); 119(3), 364-373. doi:10.1038/s41416-018-0097-7. 5.922 3 Arni D, Wildhaber BE, McLin V, Rimensberger PC, Ansari M, Fontana P, Karam O. Effects of plasma transfusions on antithrombin levels after paediatric liver transplantation. Vox Sang. (2018). doi:10.1111/vox.12664. 2.107 4 Baenziger J, Roser K, Mader L, Christen S, Kuehni CE, Gumy-Pause F, Tinner EM, Michel G. Can the theory of planned behavior help explain attendance to follow-up care of childhood cancer survivors? Psychooncology. (2018); 27(6), 1501-1508. doi:10.1002/pon.4680. 3.455 5 Baleydier F, Ranza E, Schappi M, Rougemont AL, Merlini L, Ansari M, Blanchard-Rohner G. Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS): A Primary Immunodeficiency Mimicking Lymphoma. J Pediatr Hematol Oncol. (2018). doi:10.1097/MPH.0000000000001328. 1.060 6 Bartolini B, Puccinelli F, Hajdu SD, Stathopoulos C, Beck Popovic M, Munier FL, Saliou G. Middle meningeal artery occlusion for intra-arterial chemotherapy of retinoblastoma. Interv Neuroradiol. (2018), 1591019918815286. doi:10.1177/1591019918815286. 1.021 7 Bassan R, Bourquin JP, DeAngelo DJ, Chiaretti S. New Approaches to the Management of Adult Acute Lymphoblastic Leukemia. J Clin Oncol. (2018), JCO2017773648. doi:10.1200/JCO.2017.77.3648. 26.303 8 Belle FN, Kasteler R, Schindera C, Bochud M, Ammann RA, von der Weid NX, Kuehni CE; Swiss Paediatric On- cology Group. No evidence of overweight in long-term survivors of childhood cancer after glucocorticoid treatment. Can- cer. (2018); 124(17), 3576-3585. doi:10.1002/cncr.31599. 6.537 9 Belle FN, Weiss A, Schindler M, Goutaki M, Bochud M, Zimmermann K, von der Weid NX, Ammann RA, Kueh- ni CE. Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study. Am J Clin Nutr. (2018); 107(1), 3-11. doi:10.1093/ajcn/nqx006. 6.549 10 Belle FN, Wenke-Zobler J, Cignacco E, Spycher BD, Ammann RA, Kuehni CE, Zimmermann K. Overweight in child- hood cancer patients at diagnosis and throughout therapy: A multicentre cohort study. Clin Nutr. (2018). doi:10.1016/j. clnu.2018.02.022. 5.496 11 Benadiba J, Ansari M, Krajinovic M, Vachon MF, Duval M, Teira P, Cellot S, Bittencourt H. Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children. PLoS One. (2018); 13(4), e0193862. doi:10.1371/journal.pone.0193862. 2.766 12 Bennett CM, Neunert C, Grace RF, Buchanan G, Imbach P, Vesely SK, Kühne T. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II partici- pants. Pediatr Blood Cancer. (2018); 65(1). doi:10.1002/pbc.26736. 2.646 13 Benzing V, Eggenberger N, Spitzhuttl J, Siegwart V, Pastore-Wapp M, Kiefer C, Slavova N, Grotzer MA, Heinks T, Schmidt M, Conzelmann A, Steinlin M, Everts R, Leibundgut K. The Brainfit study: efficacy of cognitive training and exergaming in pe- diatric cancer survivors - a randomized controlled trial. BMC Cancer. (2018); 18(1), 18. doi:10.1186/s12885-017-3933-x. 3.288 14 Blesinger H, Kaulfuss S, Aung T, Schwoch S, Prantl L, Rössler J, Wilting J, Becker J. PIK3CA mutations are specifically loca- lized to lymphatic endothelial cells of lymphatic malformations. PLoS One. (2018); 13(7), e0200343. doi:10.1371/journal. pone.0200343. 2.766 15 Bochtler T, Kartal-Kaess M, Granzow M, Hielscher T, Cosenza MR, Herold-Mende C, Jauch A, Kramer A. Micronucleus formation in human cancer cells is biased by chromosome size. Genes Chromosomes Cancer. (2018). doi:10.1002/ gcc.22707. 3.362 Authors / title / journal Publications in peer reviewed journals JIF

Publications 2018 du SPOG

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Publications 2018 du SPOG

14

Publications 2018 du SPOG

Ci-après est présentée une liste des publications parues en 2018 dans des revues scientifiques reconnues, auxquelles

des collaborateurs du réseau du SPOG ont participé activement.

1 Adamczick C, Dierig A, Welzel T, Schifferli A, Blum J, Ritz NJBID. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany – a case report. BMC Infectious Diseases. (2018); 18(1), 495. doi:10.1186/s12879-018-3394-0.

2.620

2 Amoon AT, Crespi CM, Ahlbom A, Bhatnagar M, Bray I, Bunch KJ, Clavel J, Feychting M, Hémon D, Johansen C, Kreis C, Ma-lagoli C, Marquant F, Pedersen C, Raaschou-Nielsen O, Röösli M, Spycher BD, Sudan M, Swanson J, Tittarelli A, Tuck DM, Tynes T, Vergara X, Vinceti M, Wünsch-Filho V, Kheifets L. Proximity to overhead power lines and childhood leukaemia: an in-ternational pooled analysis. British Journal of Cancer. (2018); 119(3), 364-373. doi:10.1038/s41416-018-0097-7.

5.922

3 Arni D, Wildhaber BE, McLin V, Rimensberger PC, Ansari M, Fontana P, Karam O. Effects of plasma transfusions on antithrombin levels after paediatric liver transplantation. Vox Sang. (2018). doi:10.1111/vox.12664.

2.107

4 Baenziger J, Roser K, Mader L, Christen S, Kuehni CE, Gumy-Pause F, Tinner EM, Michel G. Can the theory of planned behavior help explain attendance to follow-up care of childhood cancer survivors? Psychooncology. (2018); 27(6), 1501-1508. doi:10.1002/pon.4680.

3.455

5 Baleydier F, Ranza E, Schappi M, Rougemont AL, Merlini L, Ansari M, Blanchard-Rohner G. Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS): A Primary Immunodeficiency Mimicking Lymphoma. J Pediatr Hematol Oncol. (2018). doi:10.1097/MPH.0000000000001328.

1.060

6 Bartolini B, Puccinelli F, Hajdu SD, Stathopoulos C, Beck Popovic M, Munier FL, Saliou G. Middle meningeal artery occlusion for intra-arterial chemotherapy of retinoblastoma. Interv Neuroradiol. (2018), 1591019918815286. doi:10.1177/1591019918815286.

1.021

7 Bassan R, Bourquin JP, DeAngelo DJ, Chiaretti S. New Approaches to the Management of Adult Acute Lymphoblastic Leukemia. J Clin Oncol. (2018), JCO2017773648. doi:10.1200/JCO.2017.77.3648.

26.303

8 Belle FN, Kasteler R, Schindera C, Bochud M, Ammann RA, von der Weid NX, Kuehni CE; Swiss Paediatric On-

cology Group. No evidence of overweight in long-term survivors of childhood cancer after glucocorticoid treatment. Can-

cer. (2018); 124(17), 3576-3585. doi:10.1002/cncr.31599.

6.537

9 Belle FN, Weiss A, Schindler M, Goutaki M, Bochud M, Zimmermann K, von der Weid NX, Ammann RA, Kueh-

ni CE. Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study. Am J Clin Nutr. (2018); 107(1), 3-11. doi:10.1093/ajcn/nqx006.

6.549

10 Belle FN, Wenke-Zobler J, Cignacco E, Spycher BD, Ammann RA, Kuehni CE, Zimmermann K. Overweight in child-hood cancer patients at diagnosis and throughout therapy: A multicentre cohort study. Clin Nutr. (2018). doi:10.1016/j.clnu.2018.02.022.

5.496

11 Benadiba J, Ansari M, Krajinovic M, Vachon MF, Duval M, Teira P, Cellot S, Bittencourt H. Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children. PLoS One. (2018); 13(4), e0193862. doi:10.1371/journal.pone.0193862.

2.766

12 Bennett CM, Neunert C, Grace RF, Buchanan G, Imbach P, Vesely SK, Kühne T. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II partici-pants. Pediatr Blood Cancer. (2018); 65(1). doi:10.1002/pbc.26736.

2.646

13 Benzing V, Eggenberger N, Spitzhuttl J, Siegwart V, Pastore-Wapp M, Kiefer C, Slavova N, Grotzer MA, Heinks T, Schmidt M, Conzelmann A, Steinlin M, Everts R, Leibundgut K. The Brainfit study: efficacy of cognitive training and exergaming in pe-diatric cancer survivors - a randomized controlled trial. BMC Cancer. (2018); 18(1), 18. doi:10.1186/s12885-017-3933-x.

3.288

14 Blesinger H, Kaulfuss S, Aung T, Schwoch S, Prantl L, Rössler J, Wilting J, Becker J. PIK3CA mutations are specifically loca-lized to lymphatic endothelial cells of lymphatic malformations. PLoS One. (2018); 13(7), e0200343. doi:10.1371/journal.pone.0200343.

2.766

15 Bochtler T, Kartal-Kaess M, Granzow M, Hielscher T, Cosenza MR, Herold-Mende C, Jauch A, Kramer A. Micronucleus formation in human cancer cells is biased by chromosome size. Genes Chromosomes Cancer. (2018). doi:10.1002/gcc.22707.

3.362

Authors / title / journal Publications in peer reviewed journals JIF

Page 2: Publications 2018 du SPOG

15

16 Bovero M, Giacomo C, Ansari M, Roulin MJ. Role of advanced nurse practitioners in the care pathway for children diagnosed with leukemia. Eur J Oncol Nurs. (2018); 36, 68-74. doi:10.1016/j.ejon.2018.08.002.

1.812

17 Bredell M, Rordorf T, Kroiss S, Rucker M, Zweifel DF, Rostetter C. Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study. J Oral Maxillofac Surg. (2018); 76(4), 775-784. doi:10.1016/j.joms.2017.09.013.

1.779

18 Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, Bardi E, Bautz A, Byrne J, Feijen EAM, Fidler MM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuehni CE, Linge H, Ofstaas H, Ronckers CM, Skinner R, Teepen JC, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lahteenmaki P, Zaletel LZ, Kuonen R, Winther JF, de Vathaire F, Kremer LC, Hjorth L, Reulen RC, PanCareSurFup C. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe. J Natl Cancer Inst. (2018); 110(6), 649-660. doi:10.1093/jnci/djx235.

11.238

19 Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B, Skeen J, Mateos ME, Capra M, Rangaswami AA, Ansari M, Rechnitzer C, Veal GJ, Covezzoli A, Brugieres L, Perilongo G, Czauderna P, Morland B, Neuwelt EA. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss. N Engl J Med. (2018); 378(25), 2376-2385. doi:10.1056/NEJMoa1801109.

79.258

20 Byrne J, Alessi D, Allodji RS, Bagnasco F, Bardi E, Bautz A, Bright CJ, Brown M, Diallo I, Feijen E, Fidler MM, Frey E, Garwicz S, Grabow D, Gudmundsdottir T, Hagberg O, Harila-Saari A, Hau EM, Haupt R, Hawkins MM, Jakab Z, Jankovic M, Kaatsch P, Kaiser M, Kremer LCM, Kuehni CE, Kuonen R, Ladenstein R, Lahteenmaki PM, Levitt G, Linge H, D LL, Michel G, Morselli-no V, Mulder RL, Reulen RC, Ronckers CM, Sacerdote C, Skinner R, Steliarova-Foucher E, van der Pal HJ, de Vathaire F, Vu Be-zin G, Wesenberg F, Wiebe T, Winter DL, Falck Winther J, Witthoff E, Zadravec Zaletel L, Hjorth L. The PanCareSurFup consor-tium: research and guidelines to improve lives for survivors of childhood cancer. Eur J Cancer. (2018); 103, 238-248. doi:10.1016/j.ejca.2018.08.017.

7.191

21 Byrne J, Grabow D, Campbell H, O'Brien K, Bielack S, Am Zehnhoff-Dinnesen A, Calaminus G, Kremer L, Langer T, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Baust K, Bautz A, Beck JD, Berger C, Binder H, Borgmann-Staudt A, Broer L, Cario H, Casagranda L, Clemens E, Deuster D, de Vries A, Dirksen U, Falck Winther J, Fossa S, Font-Gonzalez A, Grandage V, Haupt R, Hecker-Nolting S, Hjorth L, Kaiser M, Kenborg L, Kepak T, Kepakova K, Knudsen LE, Krawczuk-Rybak M, Kruseova J, Kuehni CE, Kunstreich M, Kuonen R, Lackner H, Leiper A, Loeffen EAH, Luks A, Modan-Moses D, Mulder R, Par-fitt R, Paul NW, Ranft A, Ruud E, Schilling R, Spix C, Stefanowicz J, Straubeta G, Uitterlinden AG, van den Berg M, van der Kooi AL, van Dijk M, van Leeuwen F, Zolk O, Zoller D, Kaatsch P. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. Eur J Cancer. (2018); 103, 227-237. doi:10.1016/j.ejca.2018.08.007.

7.191

22 Chatzis O, Darbre S, Pasquier J, Meylan P, Manuel O, Aubert JD, Beck Popovic M, Masouridi-Levrat S, Ansari M, Kaiser L, Posfay-Barbe KM, Asner SA. Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study. BMC Infect Dis. (2018); 18(1), 111. doi:10.1186/s12879-018-3002-3.

2.620

23 Choong E, Uppugunduri CRS, Marino D, Kuntzinger M, Doffey-Lazeyras F, Lo Piccolo R, Chalandon Y, Peters C, Daali Y, Ansari M. Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance. Ther Drug Monit. (2018); 40(1), 84-92. doi:10.1097/FTD.0000000000000468.

2.092

24 Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Güngör T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P. Diagnosis and severity criteria for sinusoidal obs-truction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. (2018); 53(2), 138-145. doi:10.1038/bmt.2017.161.

4.497

25 Diorio C, Robinson PD, Ammann RA, Castagnola E, Erickson K, Esbenshade A, Fisher BT, Haeusler GM, Kuczynski S, Lehrn-becher T, Phillips R, Cabral S, Dupuis LL, Sung L. Guideline for the management of Clostridium difficile infection in children and adolescents with cancer and pediatric hematopoietic stem cell transplantation recipients. J Clin Oncol (2018); 36: 3162-3171

26.303

26 Drozdov D, Bonaventure A, Nakata K, Suttorp M, Belot A. Temporal trends in the proportion of «cure» in children, adoles-cents, and young adults diagnosed with chronic myeloid leukemia in England: A population-based study. Pediatr Blood Can-

cer. (2018); 65(12), e27422. doi:10.1002/pbc.27422.

2.646

27 Dworzak MN, Buldini B, Gaipa G, Ratei R, Hrusak O, Luria D, Rosenthal E, Bourquin JP, Sartor M, Schumich A, Karawajew L, Mejstrikova E, Maglia O, Mann G, Ludwig WD, Biondi A, Schrappe M, Basso G, International BFMFn. AIEOP-BFM consen-sus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia. Cytometry B Clin

Cytom. (2018); 94(1), 82-93. doi:10.1002/cyto.b.21518.

2.757

28 El-Ayadi M, Egervari K, Merkler D, McKee TA, Gumy-Pause F, Stichel D, Capper D, Pietsch T, Ansari M, von Büren AO. Concurrent IDH1 and SMARCB1 Mutations in Pediatric Medulloblastoma: A Case Report. Front Neurol. (2018); 9, 398. doi:10.3389/fneur.2018.00398.

3.508

Authors / title / journal Publications in peer reviewed journals JIF

Page 3: Publications 2018 du SPOG

16

29 Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bardi E, Bautz A, Bright CJ, Byrne J, Feijen EAM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuonen R, Linge H, Maule M, Merletti F, Ofstaas H, Ronckers CM, Skinner R, Teepen J, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Jakab Z, Haupt R, Lahteen-maki P, Zaletel LZ, Kuehni CE, Winther JF, de Vathaire F, Kremer LC, Hjorth L, Hawkins MM. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. J Natl Cancer Inst. (2018); 110(2). doi:10.1093/jnci/djx165.

11.238

30 Furtwangler R, Kager L, Melchior P, Rube C, Ebinger M, Nourkami-Tutdibi N, Niggli F, Warmann S, Hubertus J, Amman G, Leuschner I, Vokuhl C, Graf N, Fruhwald MC. High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH) experience. Pediatr Blood Cancer. (2018); 65(1). doi:10.1002/pbc.26746.

2.646

31 Gaertner K, Lüer SC, Frei-Erb M, von Ammon K. Complementary individual homeopathy in paediatric cancer care: A case series from a University Hospital, Switzerland. Complement Ther Med. (2018); 41, 267-270. doi:10.1016/j.ctim.2018.10.010.

2.084

32 Georgi TW, Kluge R, Kurch L, Chavdarova L, Hasenclever D, Stoevesandt D, Pelz T, Landman-Parker J, Wallace WH, Karlen J, Fernandez-Teijeiro A, Cepelova M, Fossa A, Balwierz W, Attarbaschi A, Ammann RA, Pears J, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Baumann J, Korholz D, Sabri O, Mauz-Korholz C. (18)F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required? J Nucl Med. (2018); 59(10), 1524-1530. doi:10.2967/jnumed.117.205633.

7.439

33 Gerth-Kahlert C, Tiwari A, Hauri-Hohl MM, Hanson JVM, Bahr A, Palmowski-Wolfe A, Güngör T, Berger W. Unusual retino-pathy in a child with severe combined immune deficiency. Ophthalmic Genet. (2018); 39(1), 92-94. doi:10.1080/13816810.2017.1350721.

1.574

34 Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, Bagnasco F, Bardi E, Bautz A, Bright CJ, de Vathaire F, Feijen EAM, Garwicz S, Hagberg O, Haupt R, Hawkins MM, Jakab Z, Kremer LCM, Kuehni CE, Kuonen R, Lahteenmaki PM, Reulen RC, Ronckers CM, Sacerdote C, Vu-Bezin G, Wesenberg F, Wiebe T, Winter DL, Winther JF, Zaletel LZ, Kaatsch P, PanCareSurFup C. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Eur J Epidemiol. (2018); 33(3), 335-349. doi:10.1007/s10654-018-0370-3.

7.023

35 Greiner J, Schrappe M, Claviez A, Zimmermann M, Niemeyer C, Kolb R, Eberl W, Berthold F, Bergsträsser E, Gnekow A, Lassay E, Vorwerk P, Lauten M, Sauerbrey A, Rischewski J, Beilken A, Henze G, Korte W, Moricke A. THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophy-laxis during inudction therapy of acute lymphoblastic leukemia in children and adolescents. Haematologica. (2018). doi:10.3324/haematol.2018.194175.

9.090

36 Harju E, Roser K, Dehler S, Michel G. Health-related quality of life in adolescent and young adult cancer survivors. Support Care Cancer. (2018); 26(9), 3099-3110. doi:10.1007/s00520-018-4151-z.

2.676

37 Heinemann M, Ranft A, Langer T, Jurgens H, Kreyer J, Vieth V, Schafers M, Weckesser M, Simon T, Hassenpflug W, Corbacio-glu S, Bielack S, Mayer-Steinacker R, Kühne T, van den Berg H, Gelderblom H, Bauer S, Stegger L, Dirksen U. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage? Pediatr Blood Cancer. (2018); 65(7), e27011. doi:10.1002/pbc.27011.

2.646

38 Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulle-man E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer

MA, Pfaff E, von Büren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biasso-ni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Re-gistries. J Clin Oncol. (2018); 36(19), 1963-1972. doi:10.1200/JCO.2017.75.9308.

26.303

39 Jankovic M, Haupt R, Spinetta JJ, Beck JD, Byrne J, Calaminus G, Lackner H, Biondi A, Oeffinger K, Hudson M, Skinner R, Reaman G, van der Pal H, Kremer L, den Hartogh J, Michel G, Frey E, Bardi E, Hawkins M, Rizvi K, Terenziani M, Valsecchi MG, Bode G, Jenney M, de Vathaire F, Garwicz S, Levitt GA, Grabow D, Kuehni CE, Schrappe M, Hjorth L, participants in P. Long-term survivors of childhood cancer: cure and care-the Erice Statement (2006) revised after 10 years (2016). J Cancer

Surviv. (2018); 12(5), 647-650. doi:10.1007/s11764-018-0701-0.

3.713

40 Janssens GO, Kramm CM, von Büren AO. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients? J Neurooncol. (2018); 139(2), 501. doi:10.1007/s11060-018-2871-z.

3.060

41 Johnston DL, Keene D, Strother D, Taneva M, Lafay-Cousin L, Fryer C, Scheinemann K, Carret AS, Fleming A, Afzal S, Wilson B, Bowes L, Zelcer S, Mpofu C, Silva M, Larouche V, Brossard J, Bouffet E. Survival Following Tumor Recurrence in Children With Medulloblastoma. J Pediatr Hematol Oncol. (2018); 40(3), e159-e163. doi:10.1097/MPH.0000000000001095.

1.060

Authors / title / journal Publications in peer reviewed journals JIF

Page 4: Publications 2018 du SPOG

17

42 Jyotsana N, Sharma A, Chaturvedi A, Scherr M, Kuchenbauer F, Sajti L, Barchanski A, Lindner R, Noyan F, Suhs KW, Grote-Koska D, Brand K, Vornlocher HP, Stanulla M, Bornhauser B, Bourquin JP, Eder M, Thol F, Ganser A, Humphries RK, Ram-say E, Cullis P, Heuser M. RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo. Leuke-

mia. (2018); 32(1), 224-226. doi:10.1038/leu.2017.269.

10.023

43 Karow A, Wilhelm A, Ammann RA, Baerlocher GM, Pabst T, Mansouri Taleghani B, Rössler J, Leibundgut K. Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow. Bone Marrow Transplant. (2018). doi:10.1038/s41409-018-0353-8.

4.497

44 Karremann M, Gielen GH, Hoffmann M, Wiese M, Colditz N, Warmuth-Metz M, Bison B, Claviez A, van Vuurden DG, von Büren AO, Gessi M, Kuhnle I, Hans VH, Benesch M, Sturm D, Kortmann RD, Waha A, Pietsch T, Kramm CM. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol. (2018); 20(1), 123-131. doi:10.1093/neuonc/nox149.

9.384

45 Kasteler R, Kam LMH, Weiss A, Waespe N, Sommer G, Singer F, von der Weid NX, Ansari M, Kuehni CE; Swiss

Paediatric Oncology Group. Monitoring pulmonary health in Swiss childhood cancer survivors. Pediatr Blood Cancer. (2018); 65(10), e27255. doi:10.1002/pbc.27255.

2.646

46 Kasteler R, Weiss A, Schindler M, Sommer G, Latzin P, von der Weid NX, Ammann RA, Kuehni CE; Swiss

Paediatric Oncology Group. Long-term pulmonary disease among Swiss childhood cancer survivors. Pediatr Blood

Cancer. (2018); 65(1). doi:10.1002/pbc.26749.

2.646

47 Kaufmann A, Gerber NU, Kandels D, Azizi AA, Schmidt R, Warmuth-Metz M, Pietsch T, Kortmann RD, Gnekow AK, Grotzer MA. Management of Primary Tectal Plate Low-Grade Glioma in Pediatric Patients: Results of the Multicenter Treat-ment Study SIOP-LGG 2004. Neuropediatrics. (2018); 49(5), 314-323. doi:10.1055/s-0038-1660503.

1.605

48 Konstantinoudis G, Kreis C, Ammann RA, Niggli F, Kuehni CE, Spycher BD; Swiss Paediatric Oncology Group, Swiss National Cohort Study G. Spatial clustering of childhood cancers in Switzerland: a nationwide study. Cancer Causes

Control. (2018); 29(3), 353-362. doi:10.1007/s10552-018-1011-6.

2.728

49 Kube S, Vokuhl C, Dantonello T, Scheer M, Hallmen E, Feuchtgruber S, Escherich G, Niggli F, Kuehnle I, von Kalle T, Bielack S, Klingebiel T, Koscielniak E. Inflammatory myofibroblastic tumors-A retrospective analysis of the Cooperative Weichteilsar-kom Studiengruppe. Pediatr Blood Cancer. (2018); 65(6), e27012. doi:10.1002/pbc.27012.

2.646

50 Kuhlen M, Willasch AM, Dalle JH, Wachowiak J, Yaniv I, Ifversen M, Sedlacek P, Güngör T, Lang P, Bader P, Sufliarska S, Bal-duzzi A, Strahm B, von Luettichau I, Hoell JI, Borkhardt A, Klingebiel T, Schrappe M, von Stackelberg A, Glogova E, Poetschger U, Meisel R, Peters C. Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial. Br J Haematol. (2018); 180(1), 82-89. doi:10.1111/bjh.14965.

5.128

51 Kühne T. Advances in chemical pharmacotherapy for the treatment of pediatric immune thrombocytopenia. Expert Opin

Pharmacother. (2018); 19(7), 667-676. doi:10.1080/14656566.2018.1458091.3.475

52 Ladenstein R, Potschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. Lancet Oncol. (2018); 19(12), 1617-1629. doi:10.1016/s1470-2045(18)30578-3.

36.418

53 Lagreze WA, Joachimsen L, Gross N, Taschner C, Rössler J. Sirolimus-induced regression of a large orbital lymphangioma. Orbit. (2018), 1-2. doi:10.1080/01676830.2018.1436569.

0.820

54 Lehrnbecher T, Groll A, Agyeman P, Ammann RA, Attarbaschi A, Behrends U, Berger C, Hamprecht A, Hufnagel M, Laws H-J, Scheler M, Temme C, Vieth S, Simon A. Empfehlungen zur Diagnostik und Therapie bei krebskranken Kindern mit Fieber und Neutropenie – Vergleich zweier aktueller Leitlinien. [Recommendations for Diagnostics and Therapy of Children with Cancer Presenting with Fever and Neutropenia – Comparison of Two Current Guidelines]. Klin Padiatr. (2018); 230(03), 115-121. doi:10.1055/s-0044-101953.

0.698

55 Mader L, Roser K, Baenziger J, Vetsch J, Winther JF, Scheinemann K, Michel G. Relationship status and quality of the partner relationship in parents of long-term childhood cancer survivors: The Swiss Childhood Cancer Survivor Study- Parents. Psychooncology. (2018). doi:10.1002/pon.4941.

3.455

56 Makarova O, Oschlies I, Muller S, Ruf S, Zimmermann M, Niggli F, Attarbaschi A, Kabickova E, Klapper W, Woessmann W, Burkhardt B. Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma. Br J Haematol.

(2018); 182(5), 735-739. doi:10.1111/bjh.14868.

5.128

57 Matzdorff A, Meyer O, Ostermann H, Kiefel V, Eberl W, Kühne T, Pabinger I, Rummel M. Immunthrombozytopenie – aktuelle Diagnostik und Therapie: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, OGHO, SGH, GPOH und DGTI. Oncol Res Treat. (2018); 41 Suppl 2, 5-36. doi:10.1159/000486384.

1.494

58 Moreno L, Casanova M, Chisholm JC, Berlanga P, Chastagner PB, Baruchel S, Amoroso L, Gallego Melcon S, Gerber NU, Bi-sogno G, Fagioli F, Geoerger B, Glade Bender JL, Aerts I, Bergeron C, Hingorani P, Elias I, Simcock M, Ferrara S, Le Bruchec Y, Slepetis R, Chen N, Vassal G. Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recur-rent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. Eur J Cancer. (2018); 100, 27-34. doi:10.1016/j.ejca.2018.05.002.

7.191

Authors / title / journal Publications in peer reviewed journals JIF

Page 5: Publications 2018 du SPOG

59 Munier FL, Moulin A, Gaillard MC, Bongiovanni M, Decembrini S, Houghton S, Beck Popovic M, Stathopoulos C. Intra-cameral Chemotherapy for Globe Salvage in Retinoblastoma with Secondary Anterior Chamber Invasion. Ophthalmology. (2018); 125(4), 615-617. doi:10.1016/j.ophtha.2017.11.010.

7.479

60 Nava T, Kassir N, Rezgui MA, Uppugunduri CRS, Huezo-Diaz Curtis P, Duval M, Theoret Y, Daudt LE, Litalien C, Ansari M, Krajinovic M, Bittencourt H. Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV bu-sulfan in paediatric hematopoietic stem cell transplantation. Br J Clin Pharmacol. (2018); 84(7), 1494-1504. doi:10.1111/bcp.13566.

3.838

61 Nava T, Rivard GE, Bonnefoy A. Challenges on the diagnostic approach of inherited platelet function disorders: Is a paradigm change necessary? Platelets. (2018); 29(2), 148-155. doi:10.1080/09537104.2017.1356918.

2.356

62 Nikkila A, Kendall G, Raitanen J, Spycher BD, Lohi O, Auvinen A. Effects of incomplete residential histories on studies of environmental exposure with application to childhood leukaemia and background radiation. Environ Res. (2018); 166, 466-472. doi:10.1016/j.envres.2018.06.035.

4.732

63 Otth M, Scheinemann K. Surveillance imaging for high-grade childhood brain tumors: What to do 10 years after completion of treatment? Pediatr Blood Cancer. (2018); 65(11), e27311. doi:10.1002/pbc.27311.

2.646

64 Passweg JR, Baldomero H, Ansari M, Baerlocher GM, Bargetzi M, Chalandon Y, Duchosal MA, Gerull S, Güngör T, Halter JP, Heim D, Hess U, Leibundgut K, Masouridi-Levrat S, Muller A, Nair G, Pabst T, Renner C, Schmidt A, Stussi G, Nicoloso de Faveri G, Schanz U. For The Swiss Blood Stem Cell Transplantation Group S. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016. Swiss Med Wkly. (2018); 148, w14589. doi:10.4414/smw.2018.14589.

1.928

65 Pfeifer U, Gubler D, Bergsträsser E, Bassler D. Congenital malformations, palliative care and postnatal redirection to more intensive treatment – a review at a Swiss tertiary center. J Matern Fetal Neonatal Med. (2018); 31(9), 1182-1187. doi:10.1080/14767058.2017.1311317.

1.493

66 Place AE, Goldsmith K, Bourquin JP, Loh ML, Gore L, Morgenstern DA, Sanzgiri Y, Hoffman D, Zhou Y, Ross JA, Prine B, Shebley M, McNamee M, Farazi T, Kim SY, Verdugo M, Lash-Fleming L, Zwaan CM, Vormoor J. Accelerating drug develop-ment in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. Future Oncol. (2018); 14(21), 2115-2129. doi:10.2217/fon-2018-0121.

2.369

67 Rasche M, Zimmermann M, Borschel L, Bourquin JP, Dworzak M, Klingebiel T, Lehrnbecher T, Creutzig U, Klusmann JH, Reinhardt D. Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia. (2018); 32(10), 2167-2177. doi:10.1038/s41375-018-0071-7.

10.023

68 Richter-Pechanska P, Kunz JB, Bornhauser B, von Knebel Doeberitz C, Rausch T, Erarslan-Uysal B, Assenov Y, Frismantas V, Marovca B, Waszak SM, Zimmermann M, Seemann J, Happich M, Stanulla M, Schrappe M, Cario G, Escherich G, Bakhare-vich K, Kirschner-Schwabe R, Eckert C, Muckenthaler MU, Korbel JO, Bourquin JP, Kulozik AE. PD models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia. EMBO Mol Med. (2018); 10(12). doi:10.15252/emmm.201809443.

10.293

69 Rock N, Ansari M, Villard J, Ferrari-Lacraz S, Waldvogel S, McLin VA. Factors associated with immune hemolytic anemia af-ter pediatric liver transplantation. Pediatr Transplant. (2018); 22(5), e13230. doi:10.1111/petr.13230.

1.377

70 Roser K, Baenziger J, Mader L, Christen S, Dehler S, Michel G. Attendance to Follow-Up Care in Survivors of Adolescent and Young Adult Cancer: Application of the Theory of Planned Behavior. J Adolesc Young Adult Oncol. (2018); 7(5), 584-591. doi:10.1089/jayao.2018.0010.

2.167

71 Rost M, Acheson E, Kühne T, Ansari M, Pacurari N, Brazzola P, Niggli F, Elger BS, Wangmo T. Palliative care in Swiss pe-diatric oncology settings: a retrospective analysis of medical records. Support Care Cancer. (2018); 26(8), 2707-2715. doi:10.1007/s00520-018-4100-x.

2.676

72 Rost M, Wangmo T, Rakic M, Acheson E, Rischewski J, Hengartner H, Kühne T, Elger BS. Burden of treatment in the face of childhood cancer: A quantitative study using medical records of deceased children. Eur J Cancer Care (Engl). (2018); 27(6), e12879. doi:10.1111/ecc.12879.

2.409

73 Santhana Kumar K, Neve A, Guerreiro Stücklin AS, Kuzan-Fischer CM, Rushing EJ, Taylor MD, Tripolitsioti D, Behrmann L, Kirschenbaum D, Grotzer MA, Baumgartner M. TGF- Determines the Pro-migratory Potential of bFGF Signaling in Me-dulloblastoma. Cell Reports. (2018); 23(13), 3798-3812.e3798. doi:10.1016/j.celrep.2018.05.083.

8.032

74 Schifferli A, Holbro A, Chitlur M, Coslovsky M, Imbach P, Donato H, Elalfy M, Graciela E, Grainger J, Holzhauer S, Riccheri C, Rodeghiero F, Ruggeri M, Tamary H, Uglova T, Wu R, Kühne T, Intercontinental Cooperative ITPSG. A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up. Am J Hematol. (2018); 93(6), 751-759. doi:10.1002/ajh.25086.

5.303

18

Authors / title / journal Publications in peer reviewed journals JIF

Page 6: Publications 2018 du SPOG

19

75 Schrappe M, Bleckmann K, Zimmermann M, Biondi A, Moricke A, Locatelli F, Cario G, Rizzari C, Attarbaschi A, Valsecchi MG, Bartram CR, Barisone E, Niggli F, Niemeyer C, Testi AM, Mann G, Ziino O, Schafer B, Panzer-Grumayer R, Beier R, Parasole R, Gohring G, Ludwig WD, Casale F, Schlegel PG, Basso G, Conter V. Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). J Clin Oncol. (2018); 36(3), 244-253. doi:10.1200/JCO.2017.74.4946.

26.303

76 Seidel C, von Büren AO, Bojko S, Hoffmann M, Pietsch T, Gielen GH, Warmuth-Metz M, Bison B, Kortmann RD, Kramm CM. Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regi-men: Acute toxicity in pediatric high-grade glioma patients. Strahlenther Onkol. (2018); 194(3), 215-224. doi:10.1007/s00066-017-1218-6.

2.459

77 Simons L, Ma K, de Chappedelaine C, Moiranghtem RD, Elkaim E, Olivre J, Susini S, Appourchaux K, Reimann C, Sadek H, Pelle O, Cagnard N, Magrin E, Lagresle-Peyrou C, Taghon T, Rausell A, Cavazzana M, Andre-Schmutz I. Generation of adult human T-cell progenitors for immunotherapeutic applications. J Allergy Clin Immunol. (2018); 141(4), 1491-1494 e1494. doi:10.1016/j.jaci.2017.10.034.

13.258

78 Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachee-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grune-baum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora KW, Tamura S, Taskinen M, Wawer A, Wolska-Kusnierz B, Cowan MJ, Fischer A, Gennery AR, Inborn Er-rors Working Party of the European Society for B, Marrow T, the European Society for I, Stem Cell Transplant for Immunodeficiencies in E, Center for International B, Marrow Transplant R, Primary Immunodeficiency Treatment C. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. J Allergy Clin Immunol.

(2018); 141(1), 322-328 e310. doi:10.1016/j.jaci.2017.02.036.

13.258

79 Sommer C, Gumy Pause F, Diezi M, Rougemont AL, Wildhaber BE. A National Long-Term Study of Neuroendocrine Tumors of the Appendix in Children: Are We Too Aggressive? Eur J Pediatr Surg. (2018). doi:10.1055/s-0038-1667032.

1.494

80 Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Leuschner I, Scheer M, Munter M, Ljungman G, Bielack SS, Niggli F, Ladenstein R, Klingebiel T, Fuchs J, Koscielniak E, Group CWSS. Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr Blood Cancer. (2018); 65(5), e26943. doi:10.1002/pbc.26943.

2.646

81 Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Scheer M, Munter M, Bielack SS, Kazanowska B, Ladenstein R, Niggli F, Klingebiel T, Fuchs J, Koscielniak E, Group CWSS. Alveolar soft-part sarcoma: Primary metastatic disease and metastatic relapse occurring during long-term follow-up: Treatment results of four Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Pediatr Blood Cancer. (2018); 65(12), e27405. doi:10.1002/pbc.27405.

2.646

82 Stanulla M, Dagdan E, Zaliova M, Moricke A, Palmi C, Cazzaniga G, Eckert C, Te Kronnie G, Bourquin JP, Bornhauser B, Koehler R, Bartram CR, Ludwig WD, Bleckmann K, Groeneveld-Krentz S, Schewe D, Junk SV, Hinze L, Klein N, Kratz CP, Bion-di A, Borkhardt A, Kulozik A, Muckenthaler MU, Basso G, Valsecchi MG, Izraeli S, Petersen BS, Franke A, Dorge P, Steinemann D, Haas OA, Panzer-Grumayer R, Cave H, Houlston RS, Cario G, Schrappe M, Zimmermann M, Consortium T, International BFMSG. IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. J Clin Oncol. (2018); 36(12), 1240-1249. doi:10.1200/JCO.2017.74.3617.

26.303

83 Stathopoulos C, Gaillard MC, Moulin A, Puccinelli F, Beck Popovic M, Munier FL. Intravitreal anti-vascular endothelial growth factor for the management of neovascularization in retinoblastoma after intravenous and/or intraarterial chemothe-rapy: Long-Term Outcomes in a Series of 35 Eyes. Retina. (2018). doi:10.1097/IAE.0000000000002339.

4.013

84 Stathopoulos C, Gaillard MC, Puccinelli F, Maeder P, Hadjistilianou D, Beck Popovic M, Munier F. Response to Khetan and Maitray's «Comment: Conservative management of massive choroidal relapse in retinoblastoma patients?». Ophthalmic

Genet. (2018); 39(3), 417. doi:10.1080/13816810.2018.1453986.

1.574

85 Stathopoulos C, Gaillard MC, Puccinelli F, Maeder P, Hadjistilianou D, Beck Popovic M, Munier FL. Successful conservative treatment of massive choroidal relapse in 2 retinoblastoma patients monitored by ultrasound biomicroscopy and/or spectral domain optic coherence tomography. Ophthalmic Genet. (2018); 39(2), 242-246. doi:10.1080/13816810.2017.1393826.

1.574

86 Tirado-Gonzalez I, Czlonka E, Nevmerzhitskaya A, Soetopo D, Bergonzani E, Mahmoud A, Contreras A, Jeremias I, Platzbec-ker U, Bourquin JP, Kloz U, Van der Hoeven F, Medyouf H. CRISPR/Cas9-edited NSG mice as PD models of human leuke-mia to address the role of niche-derived SPARC. Leucémie (2018); 32(4), 1049-1052. doi:10.1038/leu.2017.346.

10.023

87 Tonorezos ES, Barnea D, Cohn RJ, Cypriano MS, Fresneau BC, Haupt R, Hjorth L, Ishida Y, Kruseova J, Kuehni CE, Kurkure PA, Langer T, Nathan PC, Skeen JE, Skinner R, Tacyildiz N, van den Heuvel-Eibrink MM, Winther JF, Hudson MM, Oeffinger KC. Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade. J Clin Oncol. (2018); 36(21), 2223-2230. doi:10.1200/JCO.2017.76.5180.

26.303

Authors / title / journal Publications in peer reviewed journals JIF

Page 7: Publications 2018 du SPOG

20

88 Tripolitsioti D, Kumar KS, Neve A, Migliavacca J, Capdeville C, Rushing EJ, Ma M, Kijima N, Sharma A, Pruschy M, McComb S, Taylor MD, Grotzer MA, Baumgartner M. MAP4K4 controlled integrin beta1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells. Oncotarget. (2018); 9(33), 23220-23236. doi:10.18632/oncotarget.25294.

5.168

89 Tyagi AK, Khoshbeen MB, Curtis PH-D, Uppugunduri CRS, Ansari M. Development and validation of an allele-specific PCR assay for genotyping a promoter and exonic single nucleotide polymorphisms of MGMT gene. J Biol Methods. (2018); 5 (2): e92. doi:10.14440/jbm.2018.224.

0.630

90 Vaezipour N, Leibundgut K. Nonalimental Scurvy With Relapse Symptoms After Stopping Oral Vitamin C Supplementa-tion. Pediatrics. (2018); 142(2). doi:10.1542/peds.2017-2139.

5.515

91 van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, Calaminus G, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, Kremer LC, Kruseova J, Kuehni CE, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Morsellino V, Spix C, Kaatsch P, van Dulmen-den Broeder E, PanCare LC. Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE). JMIR Res Protoc. (2018); 7(9), e10824. doi:10.2196/10824.

-

92 van Straaten S, Bierings M, Bianchi P, Akiyoshi K, Kanno H, Serra IB, Chen J, Huang X, van Beers E, Ekwattanakit S, Güngör T, Kors WA, Smiers F, Raymakers R, Yanez L, Sevilla J, van Solinge W, Segovia JC, van Wijk R. Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency. Haematologica. (2018); 103(2), e82-e86. doi:10.3324/haematol.2017.177857.

9.090

93 Vanden Bempt M, Demeyer S, Broux M, De Bie J, Bornschein S, Mentens N, Vandepoel R, Geerdens E, Radaelli E, Bornhau-

ser B, Kulozik AE, Meijerink JP, Bourquin JP, de Bock CE, Cools J. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia. Cancer Cell. (2018); 34(2), 271-285 e277. doi:10.1016/j.ccell.2018.07.007.

22.844

94 Vetsch J, Rueegg CS, Mader L, Bergsträsser E, Diezi M, Kuehni CE, Michel G; Swiss Paediatric Oncology Group. Parents' preferences for the organisation of long-term follow-up of childhood cancer survivors. Eur J Cancer Care (Engl). (2018); 27(2), e12649. doi:10.1111/ecc.12649.

2.409

95 von Allmen AN, Zermatten MG, Leibundgut K, Agyeman P, Ammann RA. Pediatric patients at risk for fever in chemothe-rapy-induced neutropenia in Bern, Switzerland, 1993-2012. Sci Data. (2018); 5, 180038. doi:10.1038/sdata.2018.38.

5.305

96 von Büren AO, Karremann M, Gielen GH, Benesch M, Fouladi M, van Vuurden DG, van Zanten S, Hoffman LM, Kramm CM. A suggestion to introduce the diagnosis of «diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)». Acta

Neuropathol. (2018); 136(1), 171-173. doi:10.1007/s00401-018-1863-6.

15.872

97 Wagner S, Brack EK, Stutz-Grunder E, Agyeman P, Leibundgut K, Teuffel O, Ammann RA. The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer. PLoS One. (2018); 13(2), e0193227. doi:10.1371/journal.pone.0193227.

2.766

98 Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugieres L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou , Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernaiz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feych-ting M, Lannering B, Schuz J, Johansen C, Andersen TV, Roosli M, Kuehni CE, Grotzer MA, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM. Spectrum and prevalence of genetic predisposi-tion in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet

Oncol. (2018); 19(6), 785-798. doi:10.1016/S1470-2045(18)30242-0.

36.418

99 Weiss A, Kuonen R, Brockmeier H, Grotzer MA, Candreia C, Maire R, Senn P, Stieger C, Rosenfeld J, Veraguth D, Kompis M, Scheinemann K, Kuehni CE; Swiss Paediatric Oncology Group. Audiological monitoring in Swiss childhood can-cer patients. Pediatr Blood Cancer. (2018); 65(3). doi:10.1002/pbc.26877.

2.646

100 Weiss A, Sommer G, Schindera C, Wengenroth L, Karow A, Diezi M, Michel G, Kuehni CE; Swiss Paediatric On-

cology Group. Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers. Qual Life Res. (2019); 28(2), 515-521. doi:10.1007/s11136-018-2021-2.

2.392

101 Wray-Dutra MN, Chawla R, Thomas KR, Seymour BJ, Arkatkar T, Sommer KM, Khim S, Trapnell C, James RG, Rawlings DJ. Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation. J Exp Med. (2018); 215(9), 2445-2461. doi:10.1084/jem.20180230.

10.790

Authors / title / journal Publications in peer reviewed journals JIF

Page 8: Publications 2018 du SPOG

21

102 Zimmermann K, Cignacco E, Engberg S, Ramelet AS, von der Weid NX, Eskola K, Bergsträsser E, Consortium P, Ansari M, Aebi C, Baer R, Beck Popovic M, Bernet V, Brazzola P, Bucher HU, Buder R, Cagnazzo S, Dinten B, Dorsaz A, Elmer F, Enriquez R, Fahrni-Nater P, Finkbeiner G, Frey B, Frey U, Greiner J, Hassink RI, Keller S, Kretschmar O, Kroell J, Laubscher B, Leibundgut K, Malär R, Meyer A, Stuessi C, Nelle M, Neuhaus T, Niggli F, Perrenoud G, Pfammatter JP, Plecko B, Rupf D, Sennhauser F, Stade C, Steinlin M, Stoffel L, Thomas K, Vonarburg C, von Vigier R, Wagner B, Wieland J, Wernz B. Patterns of paediatric end-of-life care: a chart review across different care settings in Switzerland. BMC Pediatr.

(2018); 18(1), 67. doi:10.1186/s12887-018-1021-2.

2.042

Total JIF 734.186

Meier JH, Ansari M, Beck Popovic M, Bergsträsser E, Brazzola P, Eisenreich B, Janz I, Hengartner H, Tinner EM, von der Weid NX, Redmond S, Scheinemann K: Aftercare in Pediatric Oncology in Switzerland – Current State, Challen-ges and Future Directions. Schweizer Krebsbulletin 2018; 3, Jg. 38: 273-279

Diesch T: Fertilitätserhaltung. Ein zunehmend wichtiger Aspekt bei krebskranken Kindern und Jugendlichen. Pädiatrie 01/2018.

Reimann C, Szavay P, Hartmann K, Eisenreich B, Rosenblatt L, Schilling FH: Three case reports on organ preserving surgery and brachytherapy in children with genitourinary rhabdomyosarcomas. Schweizer Krebsbulletin 2018; 2, Jg. 38: 184-187

Scheinemann K: Pediatric primary CNS tumors – a quick update. Schweizer Krebsbulletin 2018. 38 2 153-155

Scheinemann K: Spätfolgen nach einer Krebserkrankung im Kindesalter. Pädiatrie 2018; 1: 12-14

Scheinemann K: Spätfolgen nach einer Krebserkrankung im Kindesalter: Heilung mit Nebenwirkungen. VSAO Journal 2018; 5: 40–42.

von der Weid NX. Akute myeloische Leukämie im Kindes- und Jugendalter. Info@Onkologie_04_2018; 20-23.

von der Weid NX. Immuntherapien in der pädiatrischen Onkologie. Neue Strategien. SZO 2018; 4: 27-30.

Ansari M, Gordon E : Le cancer de l’enfant et de l’adolescent. J’ai envie de comprendre. Éditions Planète santé 2018.

Guerreiro Stücklin AS, Grotzer MA. (2018). Chapter 19 – Cerebellar tumors. In: Manto M, Huisman TAGM (Eds.), Handbook of Clinical Neurology (Vol. 155, pp. 289-299): Elsevier.

Kühne T. Primäre Immunthrombozytopenie. In: Pädiatrische Hämatologie und Onkologie (Niemeyer C und Eggert A., Hrsg.). Springer-Verlag Deutschland 2018;127-130.

Kühne T: Registries in Immune Thrombocytopenia: The History of the Intercontinental Cooperative ITP Study Group. In: Imbach P. Antibody Therapy. Substitution – Immunomodulation – Monoclonal Immunotherapy. Springer Verlag, Berlin, Heidelberg 2018; 277-287.

Lehrnbecher T, Ammann RA, Berger C, Groll AH, Kontny U, Laws HJ, Simon A, Strenger V. Infektionen bei pädiatrisch-onko-logischen Patienten. In DGPI. DGPI Handbuch Infektionen bei Kindern und Jugendlichen.7. Auflage. Stuttgart, New York: Thieme 2018; 317-327.

Simon A, Furtwängler R, Laws HJ, Greiner J, Lehrnbecher T, Ammann RA, Schilling FH, Graf N; im Auftrag der GPOH. Evidenzbasierte Empfehlungen zur Anwendung dauerhaft implantierter, zentralvenöser Zugänge in der pädiatrischen Onkologie. 5. Überarbeitete Auflage. Wiesbaden: mhp Verlag GmbH 2018; 84 pp.

Le Journal Impact Factor (JIF) d’une revue spécialisée mesure la fréquence à laquelle d’autres revues citent un de ses articles

par rapport au nombre total d’articles publiés. Il s’agit d’une mesure de référence concernant la reconnaissance de la qualité

de résultats de recherche publiés.

Authors / title / journal Publications in peer reviewed journals JIF

Not peer reviewed journals

Book chapters and others